Clinical and pathologic factors predicting axillary lymph node involvement in breast cancer

Breast Cancer

Volumn 7, Issue 2, 2000, Pages 114-123

  Noguchi, Masakuni ^a   Kurosumi, Masafumi ^b   Iwata, Hiroii ^c   Miyauchi, Mitsuru ^d   Ohta, Masatoshi ^e   Imoto, Shigeru ^f   Motomura, Kazuyoshi ^g   Sato, Kazuhiko ^h   Tsugawa, Koichiro ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d CHIBA CANCER CENTER   (Japan)

^e TOKAI UNIVERSITY   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^g OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^h NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Axillary lymph node metastases; Breast cancer; Sentinel lymph node biopsy

Indexed keywords

AXILLA; BREAST TUMOR; HUMAN; LYMPH NODE; MALE; PATHOLOGY; REVIEW; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; HUMANS; LYMPH NODES; MALE; SENTINEL LYMPH NODE BIOPSY;

EID: 0034565248     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967442     Document Type: Review

References (74)

1. Senofsky GM, Moffat Jr FL, Davis K, et al: Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 126:1336-1342, 1991.
2. Fentiman IS, Mansel RE: The axilla; Not a no-go zone. Lancet 337:221-223, 1991.
3. Noguchi M, Miwa K, Michigishi T, et al: The role of axiUary lymph node dissection in breast cancer management. Breast Cancer 4:143-153, 1997.
4. Fisher B, Redmond C, Fisher ER, et al: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674-681, 1985. (Pubitemid 15134703)
5. Lythgoe JP, Palmer MK: Manchester regional breast study; 5 and 10 years results. Br J Surg 69:693-696, 1982. (Pubitemid 13201853)
6. Cancer Research Campaign Working Party: Cancer Research Campaign (King's/Cambridge) trial for early breast cancer; A detailed uptake at the tenth year. Lancet 2:55-60, 1980.
7. Cady B: Case against axillary lymphadenectomy for most patients with infiltrating breast cancer. J Surg Oncol 66:7-10, 1997. (Pubitemid 27381472)
8. Veronesi U, Salvadori B, Luini A, et al: Breast conservation is a safe method in patients with small cancer of the breast; Long term results of three randomized trials on 1973 patients. Eur J Cancer 31:1574-1579, 1995.
9. Kissin MW, Querci della Rovere G, Easton D, et al: Risk of lymphedema following the treatment of breast cancer. Br J Surg 73:580-584, 1986. (Pubitemid 16013418)
10. Ivens D, Hoe L, Podd TJ, et al: Assessment of morbidity from complete axillary dissection. Br J Surg 66:136-138, 1992.
11. Noguchi M, Katev N, Miyazaki I: Diagnosis of axillary lymph node metastases in patients with breast cancer. Breast Cancer Res Treat 40:283-293, 1996. (Pubitemid 26336124)
12. March DE, Wechsler RJ, Kurtz AB, et al: CT-pathologic correlation of axillary lymph nodes in breast carcinoma. J Comput Assist Tomogr 15:440-441, 1991.
13. Sacre R: Modem thoughts on lymph nodes in breast cancer. Semin Surg Oncol 5:118-125, 1989. (Pubitemid 19130776)
14. Miyauchi M, Yamamoto N, Imanaka N, et al: Computed tomography for preoperative evaluation of axillary nodal status in breast cancer. Breast Cancer 6:243-248, 1999.
15. Ohta M, Tokuda Y, Saitoh Y, et al: Comparative efficacy of positron emission tomography and ultrasonography in preoperative evaluation of axillary lymph node metastases in breast cancer. Breast Cancer 7: 99-103, 2000.
16. Yoshimura G, Sakurai T, Oura S, et al: Evaluation of axillary lymph node status in breast cancer with MRI. Breast Cancer 6:249-258, 1999.
17. Chadha M, Chabon AB, Friedmann P, et al: Predictors of axillary lymph node metastases in patients with T1 breast cancer. Cancer 73:350-353, 1994. (Pubitemid 24030613)
18. Mitsuyama S, Anan K, Toyoshima S, et al: Histopathological predictors of axillary lymph node metastases in patients with breast cancer. Breast Cancer 6:237-241, 1999.
19. Tsuchiya A, Kanno M, Zhang GJ, et al: Predicting axillary lymph node metastases in breast cancer patients with tumors under 2 cm in size. Breast Cancer 6:167-170, 1999.
20. Noguchi M, Miyazaki I: Prognostic factors in breast cancer and their controversies (Review). Oncol Rep 1:1157-1163, 1994. (Pubitemid 2159593)
21. Noguchi M, Ohta N, Thomas M, et al: Clinical and biological prediction of axillary and internal mammary lymph node metastases in breast cancer. Surg Oncol 2:51-58, 1993. (Pubitemid 23098882)
22. Davies B, Miles DW, Happerfield LC, et al: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 67:1126-1113, 1993.
23. Iwata H, Kobayashi S, Iwase H, et al: Production of matrix metalloproteinases and tissue inhibitors metalloproteinases in human breast carcinomas. Jpn J Cancer Res 87:602-611, 1996. (Pubitemid 26235551)
24. Monteagudo C, Merino MJ, San-Juan J, et al: Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am JPathol 136:585-592, 1990. (Pubitemid 20105926)
25. Iwata H, Yamamoto M, Nemori R, et al: The localization of gelatinolytic activity can be detected in breast cancer tissues by film in situ zymography (submitted).
26. Cabanas RM: An approach for the treatment of penile carcinoma. Cancer 39:456-466, 1997.
27. Krag DN, Weaver OJ, Alex JC, et al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-340, 1993. (Pubitemid 24019852)
28. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-401, 1994. (Pubitemid 24313232)
29. Albertini JA, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patients with breast cancer. J Am Med Assoc 276:1818-1822, 1996.
30. Cody HS III: Sentinel lymph node mapping in breast cancer. Breast Cancer 6:13-22, 1999.
31. Noguchi M, Tsugawa K, Kawahara F, et al: Dye-guided sentinel lymphadenectomy in clinically nodenegative and node-positive breast cancer patients. Breast Cancer 5:381-387, 1998.
32. Motomura K, Inaji H, Komoike Y, et al: Sentinel node biopsy in breast cancer with clinically negative lymph-nodes. Breast Cancer 6:259-262, 1999.
33. Motomura K, Inaji H, Komoike Y, et al: Sentinel node biopsy guided by indocyanin green dye in breast cancer patients.Jpn J Clin Oneol 29:604-607, 1999.
34. Imoto S, Hasebe T: Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East.Jpn J Clin Oneol 29:11-15, 1999.
35. Miyauchi M: Dye-guided methods of sentinel node biopsy in breast cancer. J Clin Exp Med 192:143-146, 2000 (in Japanese).
36. Sato K, Uematsu M, Saito T, et al: Indications and technique of sentinel lymph node biopsy in breast cancer using 99m-technetium labeled tin colloid. Breast Cancer 7:95-98, 2000.
37. Tsugawa K, Noguchi M, Miwa K, et al: Dye-and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: Using patent blue dye and tecnetium-99m-labeled human serum albumin. Breast Cancer 7:87-94, 2000.
38. Noguchi M, Motomura K, Imoto S, et al: Axillary lymph node dissection can be avoided by sentinel lymph node biopsy in patients with small breast cancer; A multicenter validation study by the Japanese Breast Cancer Society (submitted).
39. Noguchi M, Bando E, Tsugawa K, et al: Staging efficacy of breast cancer with sentinel lymphadenectomy. Breast Cancer Res Treat 57:221-229, 1999. (Pubitemid 29531468)
40. Noguchi M, Tsugawa K, Miwa K, et al: Sentinel lymph node biopsy in breast cancer using blue dye with or without isotope localization (submitted).
41. Imoto S, et al: Pilot study on sentinel node biopsy in breast cancer.J Surg Oneol (in press).
42. Motomura K, Inaji H, Komoike Y, et al: Sentinel node biopsy in breast cancer. Breast Cancer 6:289-291, 1999.
43. Sato K, Hiraide H, Mochizuki H: Sentinel lymph node biopsy using technetium-99m labeled tin colloids in breast cancer. J Clin Exp Med 192:147-150, 2000 (in Japanese).
44. Roumen RMH, Valkenburg JGM, Gueskens LM: Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 23:495-502, 1997.
45. Pijpers R, Meijer S, Hoekstra OS, et al: Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer.J Nucl Med 38:366-368, 1997. (Pubitemid 27376884)
46. Borgstein PJ, Pijpers R, Comans FF et al: Sentinel lymph node biopsy in breast cancer; Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186:275-283, 1998. (Pubitemid 28124433)
47. Burak WE Jr, Walker MJ, Yee LD, et al: Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg 177:445-449, 1999. (Pubitemid 29331470)
48. Imoto S, Murakami K, Ikeda H, et al: Mammary lymphoscintigraphy with various radiopharmaceuticals in breast cancer. Ann Nucl Med 13:325-329, 1999.
49. Krag DN, Ashikaga T, Harlow SP, Weaver DL: Development of sentinel node targeting technique in breast cancer patients. Breast J 4:67-74, 1998. (Pubitemid 28176432)
50. Linehan DC, Hill ADK, Tran KN, et al: Sentinel lymph node biopsy in breast cancer; Unfiltered radioisotope is superior to filtered. J Am Coll Surg 188:377-381, 1999. (Pubitemid 29162695)
51. Paganelli G, De Cicco C, Cremonesi M, et al: Optimized sentinel node scintigraphy in breast cancer. QJ Nucl Med 42:49-53, 1998. (Pubitemid 28244267)
52. Noguchi M, Tsugawa K, Bando E, et al: Sentinel lymphadenectomy in breast cancer; Identification of sentinel lymph node and detection of metastases. Breast Cancer Res Treat 53:97-104, 1999. (Pubitemid 29161115)
53. Giuliano AE, Dale PS, Turner RR, et al: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394-401, 1995.
54. Giuliano AE: Sentinel lymphadenectomy in primary breast carcinoma; An alternative to routine axillary dissection.J Surg Oncol 62:75-77, 1996. (Pubitemid 26196502)
55. Veronesi U, Paganelli G, Galimberti V, et al: Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph node. Lancet 349:1864-1867, 1997. (Pubitemid 27270119)
56. Veronesi U, Paganelli G, Galimberti V, et al: Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph node. Lancet 349:1864-1867, 1997. (Pubitemid 27270119)
57. Viale G, Bosari S, Mazzarol G, et al: Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 85:2433-2438, 1999. (Pubitemid 29244852)
58. Hadjiminas DJ, Burke M: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 81:1615-1616, 1994. (Pubitemid 24349934)
59. Fisher CJ, Boyle S, Burke M, et al: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 80:457-458, 1993. (Pubitemid 23116082)
60. Motomura K, et al: Intraoperative sentinel lymph node examination by imprint cytology and frozen section during breast surgery (in presss).
61. Rubio IT, Korourian S, Cowan C, et al: Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 5:689-694, 1998. (Pubitemid 28565719)
62. Ratanawichitrasin A, Biscotti CV, Levy L, et al: Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer. Br J Surg 86:1346-1348, 1999. (Pubitemid 29481549)
63. O'Hea BJ, Hill ADK, El-Shirbiny AM, et al: Sentinel lymph node biopsy in breast cancer; Initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coil Surg 186:423-427, 1998. (Pubitemid 28169364)
64. Galimberti V, Zurrida S, Zucali P, et al: Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients? Breast 7:8-10, 1998. (Pubitemid 28159630)
65. Cody HS III, Hill ADK, Tran KN, et al: Credentialing for breast lymphatic mapping; How many cases are enough? Ann Surg 229:723-728, 1999. (Pubitemid 30187580)
66. Chu KU, Turner RR, Hansen NM, et al: Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 4:536-541, 1999. (Pubitemid 30191752)
67. Czerniecki B, Scheff AM, Callans LS, et al: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 85:1098-1103, 1999. (Pubitemid 29115589)
68. Giuliano AE: Mapping a pathway for axillary staging; A personal perspective on the current status of sentinel lymph node dissection for breast cancer. Arch Surg 134:195-199, 1999.
69. Noguchi M, Tsugawa K, Taniya T, et al: The role of internal mammary lymph node metastases in the management of breast cancer. Breast Cancer 5:117-125, 1998.
70. Veronesi U, Cascinelli N, Greco M, et al: Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202:702-707, 1985. (Pubitemid 16229385)
71. Cody HS, Urban JA: Internal mammary node status; A major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 2:32-37, 1995.
72. Harlow S, Krag D, Weaver D, et al: Extra-axillary sentinel lymph nodes in breast cancer. Breast Cancer 6:159-165, 1999.
73. Winchester D J, Sener SF, Winchester DP, et al: Sentinel lymphadenectomy for breast cancer; Experience with 180 consecutive patients; Efficacy of filtered technetium 99m sulfur colloid with overnight migration time. J Am Coll Surg 188:597-603, 1999. (Pubitemid 29247074)
74. Noguchi M, Tsugawa K, Miwa K: Internal mammary chain sentinel lymph node identification in breast cancer. J Surg Oncol 73:75-80, 2000. (Pubitemid 30123729)